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Cytomegaloviruses are known to encode sev-
eral gene products that function to subvert
MHC-dependent immune recognition. Here we
characterize a rat cytomegalovirus (RCMV)
C-type lectin-like (RCTL) gene product with ho-
mology to the Clr ligands for the NKR-P1 recep-
tors. RCMV infection rapidly extinguished host
Clr-b expression, thereby sensitizing infected
cells to killing by natural killer (NK) cells. How-
ever, the RCTL protein functioned as a decoy li-
gand to protect infected cells fromNK killing via
direct interaction with the NKR-P1B inhibitory
receptor. In vivo, an RCTL mutant virus dis-
played diminished virulence in an NK-depen-
dent and strain-specific manner, suggesting
that host NKR-P1 polymorphisms have evolved
to avert the viral decoy mechanism while main-
taining Clr-b recognition to preserve self toler-
ance. These findings reveal a unique strategy
adopted by cytomegaloviruses to evade MHC-
independent self-nonself discrimination. The
existence of lectin-like genes in several poxvi-
ruses suggests that this may represent a com-
mon theme for viral evasion of innate immunity.
INTRODUCTION
Natural killer (NK) cells are innate immune lymphocytes
capable of recognizing and destroying a wide variety of
target cells, including transformed, infected, transplanted,
antibody-coated, and stressed cells (Lanier, 2005). NK-
mediated self-nonself discrimination is controlled at the
molecular level by an integrated sum of stimulatory and in-
hibitory signals, transmitted via receptor-ligand interac-
tions between NK cells and their targets, respectively.
On normal cells, inhibitory ligands predominate, leading
to self-tolerance through attenuation of NK cell activation
(Kumar and McNerney, 2005; Raulet and Vance, 2006).However, in pathological states, target cells often lose in-
hibitory ‘‘self’’ ligands, leading to enhanced cytotoxicity via
disinhibition of NK cells. This mode of detection has been
designated ‘‘missing-self’’ recognition (Karre et al., 1986).
Several NK receptor families have been described, in-
cluding the NKR-P1, Ly49, and CD94-NKG2 families (Yo-
koyama and Plougastel, 2003). The best-characterized
missing-self ligands are the MHC I alleles recognized by
the Ly49 receptors in rodents and KIR receptors in hu-
mans (Lanier, 2005). Nevertheless, non-MHC missing-
self ligands for the NKR-P1 and 2B4 (CD244) receptors
have recently been identified (Kumar and McNerney,
2005; Mesci et al., 2006).
The NKR-P1 family consists of homodimeric type II
transmembrane C-type lectin-like proteins found primarily
on NK cells, NKT cells, and activated CD8+ T cells. Both
stimulatory and inhibitory NKR-P1 isoforms have been
characterized, encoded by distinct but closely related
genes found within the NK gene complex (NKC) (Mesci
et al., 2006; Yokoyama and Plougastel, 2003). Genes en-
coding the NKR-P1 family (designated Klrb1) appear to be
conserved among birds, rodents, humans, and other
mammals, suggesting that the gene products play an im-
portant role in innate immunity across species boundaries
(Hao et al., 2006; Mesci et al., 2006).
Whereas the NKR-P1 receptors were originally thought
to recognize carbohydrates (Bezouska et al., 1994), phys-
iological ligands were recently discovered and shown to
comprise a group of C-type lectin-like proteins them-
selves (Carlyle et al., 2004; Iizuka et al., 2003). Specifically,
the cognate ligands are encoded by a gene family desig-
nated Clec2 (also known as Ocil [Zhou et al., 2001] or Clr
[Plougastel et al., 2001a]), which is genetically inter-
mingled among the Klrb1 receptor genes within the
NKC. Genetic linkage of theClec2 and Klrb1 genes under-
scores the importance of this system as a particularly
unique self-nonself discrimination tool, because the
‘‘self’’ ligand is always coinherited with its cognate recep-
tor (Carlyle et al., 2004; Iizuka et al., 2003; Mesci et al.,
2006).
Only two ligands for the NKR-P1 receptors are currently
known: Clr-b is a ligand for the inhibitory NKR-P1B recep-
tor, whereas Clr-g is a ligand for the stimulatory NKR-P1FImmunity 26, 617–627, May 2007 ª2007 Elsevier Inc. 617
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eral, Clr transcripts exhibit restricted expression (Plougas-
tel et al., 2001a); however, Clr-b displays a broad expres-
sion pattern similar to that of the MHC I ligands for the
Ly49 receptors (Carlyle et al., 2004). Moreover, like MHC
I, Clr-b is frequently downregulated on many tumor cell
lines. This MHC-independent ‘‘missing-self’’ state results
in increased sensitivity of tumor cells to NK cytotoxicity
(Mesci et al., 2006). Nonetheless, the importance of this
receptor-ligand system in recognition of infected cells
remains unknown.
To date, several strategies for viral evasion of innate and
adaptive immunity have been documented, mainly via cy-
tomegalovirus (CMV) models (Lodoen and Lanier, 2005;
Reddehase, 2002; Vidal and Lanier, 2006). The majority
of CMV immunomodulatory gene products prevent T
and NK stimulation via downregulation of host proteins, in-
cluding MHC I molecules (e.g., MCMV m06, m152; HCMV
US2, US3, US6, US11) and NKG2D ligands (e.g., MCMV
m138, m145, m152, m155; HCMV UL16, UL142) (Lenac
et al., 2006; Lodoen and Lanier, 2005; Vidal and Lanier,
2006; Wills et al., 2005). However, cytomegaloviruses
also encode ‘‘decoy’’ ligands, including MHC I homologs
that directly or indirectly inhibit T and NK function (e.g.,
MCMV m04, m144, m157; HCMV UL18, UL40) (Lodoen
and Lanier, 2005; Vidal and Lanier, 2006). For example,
the MCMV m157 gene product interacts directly with the
Ly49I inhibitory receptor, whose cognate ligands include
H-2K alleles (Arase et al., 2002; Smith et al., 2002; Vidal
and Lanier, 2006). Thus, m157 plays a direct decoy role
in evasion of MHC-dependent NK recognition. However,
MHC-independent missing-self viral decoy strategies
have yet to be documented.
In this report, we characterize an orphan RCMV gene
product (RCTL) that closely resembles rat Clr-b (Mesci
et al., 2006; Voigt et al., 2001). By using a recently devel-
oped monoclonal antibody (R3A8 mAb), we show that
RCMV infection stimulates loss of rClr-b that is rapidly
countered by upregulation of RCTL surface expression.
RCTL inhibits NK killing of infected cells via direct interac-
tion with NKR-P1B. Thus, RCTL functions as a decoy li-
gand to subvert NKR-P1B-mediated missing-self recogni-
tion by NK cells. Notably, an RCTL mutant (DRCTL) virus
displays diminished virulence in vivo in a strain-dependent
manner controlled by host NKR-P1 polymorphisms. Allelic
divergence of rodent NKR-P1 receptors suggests that the
host genomes are evolving under selection pressure to
avert this viral evasion strategy (Carlyle et al., 2006; Mesci
et al., 2006). These findings reveal a nonredundant role for
NKR-P1B:Clr-b interactions in NK-mediated immunity to
infection.
RESULTS
Rat Cytomegalovirus Encodes a Viral Ortholog
of the Host Clr-b Ligand
The role of the NKR-P1B:Clr-b self-nonself discrimination
system in the detection of infected cells by NK cells
remains unknown (Kumar and McNerney, 2005; Mesci618 Immunity 26, 617–627, May 2007 ª2007 Elsevier Inc.et al., 2006). Because previous work identified a spliced
RCMV C-type lectin-like (rctl) gene with substantial ho-
mology to both Klrb1 and Clec2 genes (Voigt et al.,
2001), we analyzed this sequence further. The RCTL
gene product displays 50% and 48% amino acid identity
to mouse Clr-b and Clr-g, respectively, and 60% identity
to rat Clr-b (also known as rCLEC2D11; Figure 1A and
Table S1 in the Supplemental Data available online; Hao
et al., 2006; Plougastel et al., 2001a; Zhou et al., 2001). In-
terestingly, the rctl gene also retains an intron-exon struc-
ture similar to that of the rodent Clec2d genes (Figure 1B).
This suggests a recent evolutionary acquisition of the viral
gene from the host during a replication cycle. However,
the rctl gene has markedly diverged from the rat Clec2d11
gene. In particular, most intronic sequences have con-
tracted, and the region encoding the cytoplasmic domain
has been truncated and altered (Figures 1A and 1B). This
is expected to have consequences for the independent
regulation of RCTL expression and function relative to
the host Clr-b gene product. Therefore, we analyzed
RCTL and rClr-b expression in RCMV-infected rat embry-
onic fibroblast (REF) cells in vitro.
Reciprocal Regulation of RCTL and rClr-b
Expression during RCMV Infection In Vitro
As previously shown via RNA blotting (Voigt et al., 2001),
RT-PCR analysis demonstrated that RCTL was rapidly ex-
pressed upon RCMV infection (Figure 2A). Similar results
were seen via quantitative real-time RT-PCR analysis
(Figure S1A). Notably, RCTL transcripts were first detect-
able by 3 hr after infection, and expression was inhibited
by cycloheximide but not phosphonoacetic acid, classify-
ing rctl as an early gene (Figure S1B and data not shown;
Voigt et al., 2001). In contrast, expression of host rClr-b
was rapidly extinguished after RCMV infection, while ex-
pression of another Clr family member, rCLEC2D5 (Hao
et al., 2006), and b-actin remained relatively unaltered
(Figure 2A). The selective loss of rClr-b transcripts indi-
cated that this effect was not due to global viral interfer-
ence with host gene expression (Figure 2A; Figure S1A),
nor was it a direct consequence of RCTL expression, be-
cause a DRCTL mutant virus (Voigt et al., 2001) exhibited
the same phenotype (Figure S1A). Rather, host ligand
downregulation appeared to be an innate response trig-
gered within the cell upon virus infection.
To directly investigate expression of RCTL protein dur-
ing infection, we generated RCTL mAb (Mesci and Carlyle,
2007). One clone (R3A8 mAb, mIgMk) recognized both
RCTL and rClr-b but did not crossreact with any other
Clr (CLEC2 family) proteins (Figure 2B and data not
shown; Hao et al., 2006). The dual specificity of R3A8
mAb further underscores the similarity of RCTL and rClr-b.
Moreover, R3A8 reactivity with fresh splenocytes and
bone-marrow cells confirmed a broad expression profile
of rClr-b on hematopoietic cells ex vivo (Figure 2C), similar
to that seen for mClr-b (Carlyle et al., 2004). In order to dis-
tinguish between the viral and host proteins, we infected
REF cells in parallel with wild-type (WT) RCMV versus
DRCTL virus. In keeping with rClr-b transcript results
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Cytomegalovirus Decoy Evades NKR-P1B RecognitionFigure 1. Identification of a Clr-b Ortholog in the RCMV Genome
(A) Alignment of the rat Clr-b (rClrb), RCMV C-type lectin (RCTL), mouse Clr-b (mClrb), and mouse Clr-g (mClrg) coding sequences. Consensus
sequence (majority) is shown at the top, and amino acid positions are shown at the right; the transmembrane region is underlined. GenBank
sequences are listed in Table S3.
(B) Diagram of the intron-exon structure of Clec2d orthologs from the mouse (mClrb; designated mClec2d8), rat (rClrb; designated rClec2d11), and
RCMV (rctl). Arrows represent promoter orientation, boxes and lines indicate exons and introns, respectively, and lengths are given in kilobases below
each gene. Analyses were performed with DNAStar Lasergene 7.0 software.(Figure 2A), REF cells rapidly lost R3A8 staining in re-
sponse to infection with DRCTL virus (Figure 2D), confirm-
ing that rClr-b surface protein was downregulated during
infection. In contrast, REF cells retained then upregulated
R3A8 staining upon infection with WT RCMV (Figure 2D),
demonstrating that RCTL was maintained at the cell sur-
face. At present, we cannot rule out partial heterodimeri-
zation of RCTL and rClr-b during WT RCMV infection;
however, heterologous transfection experiments (Fig-
ure 2B and data not shown) suggest that RCTL can be ex-
pressed alone at the cell surface, likely as a homodimer.
The kinetics of rClr-b downregulation suggest that turn-
over of cell-surface protein is rapid. Yet in contrast to
MHC I downregulation, which occurs by intracellular re-
tention and degradation of ligand protein (Lodoen and
Lanier, 2005), the loss of rClr-b transcripts upon RCMV in-
fection (Figure 2A) suggests that loss of surface protein
can occur independently of other RCMV gene products.
These findings demonstrate that RCMV infection results
in modulation of rClr-b expression in a manner expected
for a missing-self ligand, whereas RCTL may function as
a decoy ligand.
Direct Interaction of RCTL with the Host NKR-P1B
Inhibitory Receptor
To determine the host receptor recognized by RCTL, we
employed our previous modification of the BWZ reportercell assay, in which a CD3z fusion protein of the receptor
of interest generates b-galactosidase activity in response
to receptor ligation by cognate ligand or specific antibody
(Carlyle et al., 2004; Mesci and Carlyle, 2007; Sanderson
and Shastri, 1994). Here, BWZ reporter cells expressing
a CD3z–RCTL fusion receptor (BWZ.RCTL) but not
BWZ control cells responded well when stimulated
with plate-bound R3A8 mAb (Figure 3A). BWZ.RCTL cells
were also stimulated by fresh ex vivo splenocytes and
bone-marrow cells (Figure 3B) and by day 5 lymphokine-
activated killer (LAK) cells (Figure 3C). Of note, the
BWZ.RCTL response to fresh splenocytes was aug-
mented relative to bone-marrow cells, whereas the re-
sponse to splenic LAK was diminished relative to bone-
marrow LAK (Figure 3B versus Figure 3C). These data
are consistent with direct interaction of RCTL with a recep-
tor expressed on NK cells and parallel the expression pat-
tern of the rNKR-P1B inhibitory receptor, which propor-
tionately decreases during splenic LAK culture (Kveberg
et al., 2006). Collectively, these results suggest that
RCTL may interact with host NKR-P1B, an interaction
that is also predicted because of the strong homology be-
tween RCTL and Clr-b, the cognate ligand for NKR-P1B in
mice (Carlyle et al., 2004).
To test this interaction, BWZ.RCTL cells were incubated
with 293T transfectants bearing rat NKR-P1 receptors.
Indeed, strong reporter activity was detected uponImmunity 26, 617–627, May 2007 ª2007 Elsevier Inc. 619
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ing rNKR-P1B, but not with untransfected 293T cells
(data not shown) or 293T transfectants expressing the re-
lated rNKR-P1F receptor (Figure 3D; Carlyle et al., 2006;
Hao et al., 2006; Mesci et al., 2006). These results reveal
that the RCTL protein interacts directly with the rNKR-
P1B receptor. Like the related mNKR-P1B (Carlyle et al.,
1999; Kung et al., 1999) and hNKR-P1A (Aldemir et al.,
2005; Rosen et al., 2005) receptors, rNKR-P1B inhibits
NK cell function (Kveberg et al., 2006; Li et al., 2003).
Figure 2. Reciprocal Regulation of RCTL and rClr-b during
RCMV Infection
(A) Time-course RT-PCR analysis of transcript expression in REF cells
during mock treatment or infection with WT-English RCMV. Lanes
show equal cDNA input via limited cycle number. Representative of
three experiments.
(B) Dual specificity of the R3A8 mAb for the viral RCTL (top) and host
rClr-b (bottom) proteins, as revealed by flow cytometric analysis.
Also shown are control stains: top, BWZ.RCTL transductants (Con;
10/78 mAb, a-NKR-P1A/B); and bottom, 293T.rCLEC2D3 transfec-
tants (R3A8 mAb). Gray shading, transductants or transfectants
(IRES-GFP+ gated); thin line, parental cell controls; RCN, relative cell
number. Representative of three experiments.
(C) Surface staining of host rClr-b protein on fresh ex vivo rat bone-
marrow cells (BM) and splenocytes (SP) via R3A8 mAb (gray shading)
relative to secondary reagent alone (thin line). Representative of two
experiments.
(D) R3A8 surface staining (gray shading) of host rClr-b versus viral
RCTL protein on uninfected REF cells (top), or REF cells infected
with DRCTL virus (left) or WT RCMV (right) over a 48 hr time course.
Control staining, 10/78 mAb (thin line). Representative of three exper-
iments. Percent positive populations are given in the upper right corner
of each panel.620 Immunity 26, 617–627, May 2007 ª2007 Elsevier Inc.Together, these findings are consistent with a decoy role
for RCTL.
The RCTL Decoy Ligand Inhibits NK Cell Function
and Augments RCMV Virulence
To assess the function of RCTL, we examined NK cytotox-
icity of REF cells either uninfected or infected with WT ver-
sus DRCTL virus. Notably, WT-infected REF target cells
were more resistant to NK killing than DRCTL-infected
REF targets at 24 hr after infection (Figure 4A). Although
the magnitude of this inhibition (WT versus DRCTL) ap-
peared to be modest, it is important to note that NKR-
P1B is expressed only by a subset of rodent NK cells
(Carlyle et al., 1999; Kung et al., 1999; Liu et al., 2000);
thus, in the rat (Kveberg et al., 2006), only half of LAK ef-
fectors are expected to be inhibited by RCTL, and other
modes of recognition on distinct or overlapping NK sub-
sets may mask RCTL inhibition. Because no specific
mAb for rNKR-P1B is commercially available (Kveberg
et al., 2006), this precluded prospective isolation of
rNKR-P1B+ effectors from their rNKR-P1B counterparts.
Figure 3. RCTL Interacts Directly with theNKR-P1B Inhibitory
NK Cell Receptor
(A) Untransduced BWZ reporter cells (BWZ) or BWZ cells expressing
a CD3z–RCTL fusion-receptor (BWZ.RCTL) were stimulated overnight
with immobilized R3A8 mAb titrated in 3-fold serial dilutions (initial con-
centration, 30 mg/mL in PBS) on 96-well plates, and b-galactosidase
activity was quantitated. Controls: PMA/ionomycin (+); media alone
(). Representative of four experiments.
(B–D) Quantitation of b-galactosidase activity after BWZ.RCTL and
BWZ reporter cell responses to various stimulator cells: (B) fresh
ex vivo hematopoietic cells (SPL, splenocytes; BM, bone-marrow
cells), (C) day 5 LAK cells, or (D) 293T transfectants expressing the
rat NKR-P1B or NKR-P1F receptors. Stimulator cells were titrated in
3-fold serial dilutions (starting with 105 cells) prior to addition of BWZ
reporter cells (5 3 104 cells). Representative of two experiments.
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infected targets was fully neutralized by R3A8 mAb
(Figure 4A; R3A8 block), directly demonstrating that
RCTL inhibits NK cell function. Because R3A8 is an IgM
isotype mAb (Mesci and Carlyle, 2007), increased killing
of WT-infected cells in the presence of R3A8 mAb is not
due to antibody-dependent cellular cytotoxicity. These
data support a direct decoy role for RCTL in functional
inhibition of NK cytotoxicity in vitro.
To determine whether RCTL functions in evasion of in-
nate immunity in vivo, we infected rats (WAG strain) with
RCMV (WT, DRCTL, or an RCTL-revertant [REV] virus)
Figure 4. RCTL Inhibits NK Cell Function In Vitro and
Augments RCMV Virulence In Vivo
(A) 51Cr-release cytotoxicity analysis with d5 LAK effectors (from WAG-
nu/nu rats) and REF targets. Uninfected REF cells or REF cells infected
overnight (24 hr) with WT or DRCTL virus (moi = 5) were used as tar-
gets, either in the absence (no mAb) or presence (R3A8 block;
25 mg/mL) of blocking R3A8 mAb. Circles, uninfected REF cells;
squares, WT-infected REF cells; triangles, DRCTL-infected REF cells.
Percent specific lysis values (±SD) obtained at 30:1 and 3:1 effector to
target (E:T) ratios are shown. Representative of three experiments.
(B) Viral titers (PFU) derived from spleens and livers of WAG rats in-
fected with WT, DRCTL, or REV virus at day 3 after infection. Viral titers
are plotted on a log10 scale, with bars indicating geometric means
(±SD). The dashed line indicates the limit of detection; both NK-
depleted (NKD) and undepleted (UND) animals are shown. DRCTL-
UND PFU titers are significantly different from all other cohorts
(p < 0.05).
(C) Viral loads of WAG tissues shown in (B) were assessed in parallel
by quantitative real-time PCR (qPCR) analysis of normalized RCMV
genome copy numbers (see Experimental Procedures). Viral loads
are plotted on a log10 scale as geometric means (±SEM). DRCTL-
UND qPCR values are significantly different from all other cohorts
(p < 0.05), except WT-NKD-Liver (p > 0.05).and assayed infected rats for viral burden early after infec-
tion (day 3). To this end, splenic and liver infectious virus
titers (PFU) were analyzed in parallel with RCMV genomic
copy numbers, the latter determined by quantitative real-
time PCR (qPCR) analysis, by normalizing RCMV glyco-
protein-B (gB) relative to host c-myc genomic copy num-
bers. Importantly, both splenic and liver PFU titers were
uniformly high in rats infected with WT or REV virus,
whereas titers from DRCTL-infected animals were below
the limit of detection (Figure 4B). The inability to detect
PFU from rats infected with DRCTL virus was not due to
lack of infection, because RCMV genomic DNA could be
detected by qPCR analysis of the same tissues, albeit at
reduced amounts compared to tissues from animals in-
fected with WT or REV virus (Figure 4C). These data dem-
onstrate that the rctl gene is sufficient to confer early viru-
lence of RCMV in vivo and that the absence of the gene
product results in more efficient clearance of RCMV, likely
by innate immunity.
To demonstrate that this effect is NK dependent, a co-
hort of rats was pretreated with the NK-depleting anti-
bodies, anti-asialo-GM-1 (Keller et al., 1983) and 3.2.3
mAb (Chambers et al., 1989). Notably, DRCTL virulence
was significantly enhanced in NK-depleted animals,
such that the differential viral burden between DRCTL-
infected animals versus WT- or REV-infected animals
was abrogated by in vivo NK depletion (Figures 4B and
4C). Collectively, these results demonstrate that the
rctl gene represents a nonredundant virulence factor
involved in RCMV evasion of NK recognition in vivo.
Allelic Divergence of Host NKR-P1B Receptor
Sequences Alters RCTL Recognition
Coding sequence alignment of RCTL with known Clr
(CLEC2 family) and NKR-P1 (KLRB1 family) sequences re-
vealed a number of interesting observations (Figures 5A
and 5B; Table S3; Hao et al., 2006). First, the RCTL
sequence most closely resembles rClr-b (rCLEC2D11)
among all known CLEC2 family members (Figure 5A;
Hao et al., 2006). Second, NKR-P1B sequences display
greater allelic polymorphism than other rodent NKR-P1
isoforms (Figure 5B; Hao et al., 2006). Notably, rNKR-
P1B alleles differ substantially among the SD, BN, F344,
BS, PVG, WAG, and TO strains (Figure 5B). Indeed, this di-
vergence has led to the alternate designation of the NKR-
P1BBS/WAG allele as a novel inhibitory NKR-P1CPVG iso-
form (Figure 5B; these sequences are identical; Kveberg
et al., 2006). Such allelic diversity also exists among the
mNKR-P1B and mNKR-P1C gene products from the B6,
SJL, BALB/c, and 129 strains (Carlyle et al., 2006; Mesci
et al., 2006). Historically, this divergence is responsible
for the alloreactivity that led to the identification of the
mouse NK1.1 antigen (Glimcher et al., 1977) and for the al-
ternate designation of the NKR-P1BB6 allele as a novel in-
hibitory NKR-P1DB6 isoform (Figure 5B; these sequences
are identical; Carlyle et al., 1999, 2006; Kung et al., 1999;
Plougastel et al., 2001b). However, only one functional in-
hibitory class Klrb1 locus has been documented in the ge-
nomes of all species to date, supporting the notion that theImmunity 26, 617–627, May 2007 ª2007 Elsevier Inc. 621
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NKR-P1B with RCTL
(A) Phylogram of coding sequences of RCTL
versus Clr family members from various spe-
cies (see Table S3 for GenBank sequences).
Scale bar indicates amino acid divergence, de-
termined with DNAStar LaserGene 7.0 soft-
ware.
(B) Phylogram of coding sequences of RCTL
versus NKR-P1 family members from various
species and strains (see Table S3 for GenBank
sequences). An asterisk (*) indicates an alter-
nate designation given to an allele derived
from the Klrb1b locus.
(C) BWZ reporter analysis of allele-specific
NKR-P1B interaction with 293T transfectants
expressing rClr-b, rCLEC2D3, or RCTL.
Quantitation of b-galactosidase activity after
responses of BWZ cells or BWZ cells
expressing CD3z–NKR-P1BRNK or CD3z–
NKR-P1BWAG fusion-receptors are shown, ei-
ther with (+) or without () R3A8 blocking
mAb (25 mg/mL). Representative of two exper-
iments.
(D) As in (C), except shown are the responses
of BWZ cells to primary REF cells, either unin-
fected (mock) or infected with WT RCMV (24 hr
prior to analysis; moi = 5). Representative of
two experiments.Klrb1 family exhibits intraspecies allelic polymorphism
rather than discrepant gene content (Carlyle et al., 2006;
Hao et al., 2006). We have previously speculated that
such directed divergence of host receptor genes may
have occurred under selection pressure from viral evasion
of NKR-P1B-mediated recognition (Mesci et al., 2006).
Strain-dependent variation in host gene content also ex-
ists in the Klra system, where the MCMV m157 gene
product directs host resistance or susceptibility via in-
teractions with the stimulatory Ly49HB6 or inhibitory
Ly49I129 receptors, respectively (Arase et al., 2002; Bubic
et al., 2004; Smith et al., 2002). Therefore, we tested other
rNKR-P1B alleles for differential interaction with the RCTL
decoy ligand.
Previously, we analyzed the rNKR-P1BWAG allele, which
is identical to the published rNKR-P1BBS/PVG sequences
(Figure 5B). Interestingly, the rNKR-P1BBS/PVG/WAG and
rNKR-P1BTO alleles have diverged substantially, whereas
the rNKR-P1BRNK,SD,BN,F344 sequences are closely related
to one another (Figure 5B). Therefore, with the BWZ assay,
we analyzed the interaction specificities of two rNKR-P1B
alleles, rNKR-P1BWAG and rNKR-P1BRNK (the latter ob-
tained from RNK-16 cells, reportedly of F344 origin [Rey-
nolds et al., 1984]). BWZ cells or BWZ cells expressing
CD3z–NKR-P1B fusion receptors were stimulated with
293T transfectants bearing various ligands. As expected,
rNKR-P1BRNK functionally recognized rClr-b but not a re-622 Immunity 26, 617–627, May 2007 ª2007 Elsevier Inc.lated family member, rCLEC2D3 (Figure 5C; Carlyle et al.,
2004; Hao et al., 2006). This interaction is specific, be-
cause it could be blocked with R3A8 mAb (Figure 5C).
However, rNKR-P1BRNK failed to recognize RCTL
(Figure 5C). In contrast, rNKR-P1BWAG functionally recog-
nized both rClr-b and RCTL (but not control rCLEC2D3;
Figure 5C). Importantly, BWZ.P1BWAG cells also recog-
nized native RCTL on RCMV-infected REF cells, but
BWZ.P1BRNK cells failed to respond (Figure 5D). These
data suggest that differential strain-dependent RCMV
susceptibility may exist in rats, similar to the strain-depen-
dent MCMV susceptibility observed in mice (Arase et al.,
2002; Bubic et al., 2004; Smith et al., 2002).
Weak Recognition of RCTL by NKR-P1A and
NKR-P1B Alleles Attenuates RCMV Virulence
We further analyzed the BWZ.RCTL reporter response to
293T transfectants bearing stimulatory and inhibitory
NKR-P1 isoforms from other rat strains. The use of
BWZ.RCTL cells also facilitated semiquantitative compar-
isons of RCTL interactions with different receptors (Mesci
and Carlyle, 2007). Notably, the rNKR-P1BWAG allele con-
sistently yielded a strong BWZ.RCTL reporter signal, while
only a weak response was detected for the rNKR-P1BSD
allele (Figure 6A). Moreover, weak interactions were
detected for both the stimulatory rNKR-P1AWAG and
rNKR-P1ASD alleles (Figure 6A). Collectively, these data
Immunity
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beit weakly) recognized by both stimulatory and inhibitory
NKR-P1 receptors in SD rats. These opposing signals (on
either distinct or overlapping NK subsets) would be ex-
pected to abrogate the RCTL decoy function, by concur-
rently weakening inhibition and inducing partial stimula-
tion (Mesci et al., 2006).
Therefore, we infected SD rats with the WT,DRCTL, and
REV viruses and assayed viral burdens in infected tissues.
As shown in Figures 6B and 6C, no differences could be
detected between the three cohorts in vivo, even though
viral loads were augmented by NK depletion. Interestingly,
the PFU titers and RCMV genomic copy numbers were
also consistently lower in SD versus WAG rats in the ab-
Figure 6. Weak Interaction of NKR-P1A and NKR-P1B Alleles
with RCTL Modulates RCMV Virulence in a Strain-Dependent
Manner
(A) Kinetic analysis of BWZ.RCTL responses to 293T transfectants ex-
pressing allelic NKR-P1 isoforms. Strong versus weak interactions
were determined by extended time-course analysis (Mesci and Car-
lyle, 2007). Various rat NKR-P1 isoforms (A, B, F, G) are shown, with
allelic designations according to rat strain (WAG, SD); also shown
are untransfected 293T cells (Con). Time course of CPRG develop-
ment: left, 1 hr; middle, 3 hr; right, 18 hr. Values indicate mean
(±SD). Representative of three experiments.
(B) Viral titers (PFU) derived from tissues of SD rats infected with WT,
DRCTL, and REV virus at day 3 after infection. The dashed line indi-
cates the limit of detection; both NK-depleted (NKD) and undepleted
(UND) animals are shown. DRCTL-UND PFU titers are not significantly
different from all other cohorts (p > 0.05).
(C) Viral loads of SD tissues shown in (B) were assessed in parallel
by qPCR analysis of normalized RCMV genome copy numbers (see
Experimental Procedures and Figure 4C for details). DRCTL-UND
qPCR values are significantly different from WT-NKD and REV-NKD
cohorts (p < 0.05), but not DRCTL-NKD (p = 0.057).sence of NK depletion (note: experiments in Figures 4B,
4C, 6B, and 6C were performed in parallel). These findings
demonstrate that strain-dependent allelic divergence of
NKR-P1 receptor sequences (Carlyle et al., 2004, 2006;
Mesci et al., 2006) can modulate the host-pathogen inter-
action: both innate host resistance to RCMV and inherent
RCMV virulence factors contribute to the outcome of
RCMV infection in vivo.
DISCUSSION
Several strategies for evasion of NK-mediated immunity
have been documented by the MCMV and HCMV models
(Lodoen and Lanier, 2005; Reddehase, 2002; Vidal and
Lanier, 2006). Here we provide evidence of a unique and
MHC-independent strategy used by RCMV to subvert
missing-self recognition mediated by the NKR-P1B:Clr-b
receptor-ligand system (Kumar and McNerney, 2005;
Mesci et al., 2006). The original discovery in the RCMV-
English genome of a C-type lectin-like sequence with sig-
nificant homology to several families of NK receptors,
such as CD69, Ly49, and NKR-P1, implicated it in regula-
tion of innate immunity (Voigt et al., 2001). Ironically, we
show here that RCTL actually represents a viral ortholog
of the host ligand for one of these receptors (Carlyle
et al., 1999, 2004). We have previously shown that the
mouse NKR-P1B:Clr-b system is involved in missing-self
recognition of tumor cells by NK cells (Carlyle et al.,
2004). Our new findings show that this mechanism also
functions in NK immunity to infectious disease.
In keeping with a proposed role in ‘‘missing-self’’ recog-
nition, rClr-b is rapidly lost on normal cells after RCMV
infection, and this sensitizes infected cells to NK killing.
Conversely, RCTL is rapidly expressed on the surface of
RCMV-infected cells in a manner expected of a decoy li-
gand. Indeed, RCTL interacts directly with rNKR-P1B on
NK cells and functions as a bona fide decoy ligand to in-
hibit NK function in vitro. Moreover, DRCTL virus is ren-
dered less virulent in vivo at an early time point after infec-
tion, demonstrating that RCTL is vitally involved in RCMV
evasion of innate immunity. Notably, DRCTL attenuation
in vivo can be reversed to wild-type levels by depletion of
NK cells, demonstrating that the immune evasion is NK
dependent. Remarkably, certain rat strains have evolved
rNKR-P1B allelic polymorphisms (Kveberg et al., 2006;
Li et al., 2003) that disrupt the RCTL decoy interaction
yet maintain host rClr-b recognition. Others have evolved
stimulatory rNKR-P1A isoforms or paralogs (Chambers
et al., 1989; Giorda et al., 1990) that directly recognize
RCTL, albeit weakly. Thus, the host genome appears to
be rapidly evolving mechanisms to counterbalance the
role of RCTL in evasion of NK recognition. Together, these
findings give us novel insights into NKR-P1 biology and
underscore the importance of NKR-P1B:Clr-b interactions
in NK-mediated immunity to infection (Carlyle et al., 2006;
Mesci et al., 2006).
The striking homology of RCTL to the rodent Clr-b se-
quences, including structural amino acid residues, nucle-
otide similarity, and conservation of intron-exon structure,Immunity 26, 617–627, May 2007 ª2007 Elsevier Inc. 623
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gene from the host during an infection cycle. CMV ge-
nomes are comparatively large among viruses, making it
possible for them to acquire large contiguous sequences.
However, rctl is one of few spliced genes found in CMV
genomes (Voigt et al., 2001), and the contraction of its in-
tronic elements relative to the host gene emphasizes that
selective pressure does exist to reduce genome size. Ad-
ditionally, divergence between the host and viral cytoplas-
mic domain sequences is substantial. This suggests that
important features of the host Clr-b protein (including pu-
tative CK2, TRAF2, ubiquitinylation, and endocytosis mo-
tifs) may have been selected against for reasons that re-
flect the functional dichotomy between the viral decoy
and physiological host proteins (Mesci et al., 2006). The
dispensable nature of the rctl gene in vitro (Voigt et al.,
2001), combined with its large size, suggests that the ab-
sence of similar lectin-like genes in MCMV and HCMV iso-
lates may reflect a loss of these elements during extended
adaptation to tissue culture (Wills et al., 2005), or alterna-
tively during the evolution of host-pathogen interactions.
The discovery of a second lectin-like sequence (r153) con-
served between RCMV-English and RCMV-Maastricht
(Brocchieri et al., 2005), as well as other lectin-like genes
encoded by several poxviruses (cited in Voigt et al.,
2001), suggests that the impact of these genes on innate
immunity is just beginning to be understood. It is possible
that functional redundancy may exist or that these new
gene products may facilitate intracellular retention of
‘‘induced-self’’ Clr ligands (Lodoen and Lanier, 2005,
2006; Raulet and Vance, 2006). On the other hand, these
gene products may disrupt NK:DC interactions during
innate priming of adaptive immunity as a distinct viral eva-
sion strategy (Iizuka et al., 2003). This latter mechanism
may be especially important in NK cell interactions with
RCMV-infected dendritic cells.
The missing-self loss of MHC I on virus-infected and tu-
mor cells is thought to occur under selection pressure to
evade T cell immunity. This inadvertently makes the target
cells sensitive to NK killing, so other mechanisms must be
invoked to counter NK recognition. Viral mechanisms for
targeting MHC I downregulation are well known (Lodoen
and Lanier, 2005; Reddehase, 2002; Vidal and Lanier,
2006), but strategies for exploiting MHC-independent
missing-self recognition are undocumented (Kumar and
McNerney, 2005). Moreover, no mechanistic basis or
cause-and-effect relationship has yet been established
regarding missing-self Clr-b downregulation on tumor
cells (Carlyle et al., 2004; Mesci et al., 2006). Neither T
nor NK cells possess any known stimulatory receptors
for Clr-b (Carlyle et al., 2004; Iizuka et al., 2003), arguing
against extrinsic selective pressure that forces loss of
the ligand. While this collectively suggests a novel mech-
anism behind the missing-self regulation of Clr-b, the ra-
tionale for cells undergoing pathological transformation
to selectively lose ligand, by proxy rendering them sensi-
tive to NK killing, remains elusive.
Our new findings shed light on this matter, in that infec-
tion alone, perhaps as a cell-autonomous stimulus, ap-624 Immunity 26, 617–627, May 2007 ª2007 Elsevier Inc.pears to be sufficient to trigger a loss of Clr-b from the sur-
face of RCMV-infected cells. Moreover, the rapid rate of
downregulation indicates that rClr-b may normally un-
dergo considerable turnover, or that post-translational
mechanisms may actively internalize ligand (Mesci et al.,
2006). Importantly, RCTL itself is not responsible for tar-
geted rClr-b downregulation; DRCTL virus induces the
same response. In fact, the loss of rClr-b at the RNA level
indicates that RCMV likely evolved the RCTL decoy to pre-
vent a functional loss of host ligand on infected cells. The
absence of rClr-b transcripts also renders unnecessary
any hypothetical viral gene products that might function
to internalize the host ligand. Rather, our findings suggest
that a programmed biological ‘‘missing-self response’’
may exist, such that innate cellular ‘‘danger’’ signals (Mat-
zinger, 2002) may trigger an automatic loss of Clr-b from
the cell surface. The pattern-recognition systems of innate
immunity represent candidate effector mechanisms (Har-
greaves and Medzhitov, 2005; Kufer et al., 2005), because
infection may initiate signals that intersect with the control
pathways regulating Clr-b expression. Of note, attempts
to induce downregulation of Clr-b on normal cells via
type I interferons or select TLR agonists have been unsuc-
cessful to date (data not shown). Thus, elucidation of the
causal mechanisms behind the missing-self response re-
mains an important focus of future work.
Intriguingly, the rodent Klrb1 sequences exhibit remark-
able polymorphism. We have previously suggested that
such allelic diversity could have evolved under selection
pressure from viral evasion of NKR-P1-mediated recogni-
tion (Mesci et al., 2006). Notably, receptor sequence di-
vergence appears to be limited to the Klrb1c–Klrb1b
genes in mice and the putatively orthologous Klrb1a–
Klrb1b genes in rats (Carlyle et al., 2006; Hao et al.,
2006). This directed Klrb1 polymorphism is in stark con-
trast to the genetic conservation of Clec2 among strains
(Carlyle et al., 2006). Our new findings suggest that the in-
hibitory NKR-P1B gene products are under pressure to
circumvent binding to viral decoys while maintaining rec-
ognition of the conserved host ligands. Conversely, the
stimulatory NKR-P1A and NKR-P1C gene products are
diverging in parallel yet exhibit the reciprocal specificity.
These findings uncouple the genetic protection of the
Klrb1 receptor and Clec2 ligand genes, arguing against
sequence conservation resulting from a mutation-sup-
pression effect from genetic linkage (Iizuka et al., 2003).
The findings reported here have several implications.
The rapid loss of rClr-b in response to RCMV infection
suggests that the NKR-P1B:Clr-b missing-self recognition
system may function as a general self-nonself discrimina-
tion rheostat to detect viral and bacterial infection, in addi-
tion to its proposed role in tumor cell immunosurveillance
(Carlyle et al., 2004; Mesci et al., 2006). In addition, the fact
that RCMV-English has evolved a decoy ligand to subvert
NKR-P1B-mediated recognition suggests that the NKR-
P1:Clr system may be a general target of evasion strate-
gies in the evolution of infectious disease. The finding
that NKR-P1-mediated recognition is conserved in hu-
mans (Aldemir et al., 2005; Rosen et al., 2005), together
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in Voigt et al., 2001), suggests that this interaction may be
clinically relevant, because such decoy proteins may rep-
resent attractive targets for therapeutic antiviral drugs.
These results profoundly influence the scope of the
original missing-self hypothesis, proposed some 20 years
ago (Karre et al., 1986). This is a direct demonstration of
MHC-independent missing-self recognition of infected
cells by NK cells, as well as a discovery of a non-MHC
decoy ligand involved in viral evasion of NK recognition.
These findings broaden the importance of the NKR-
P1:Clr receptor-ligand system in self-nonself discrimina-
tion and innate immunity to infectious disease. Future
elucidation of the proposed ‘‘missing-self response’’ path-
way may have implications for the regulation of both MHC
(Hassink et al., 2005) and non-MHC (Carlyle et al., 2004)
ligands during infection and transformation.
EXPERIMENTAL PROCEDURES
Animals and Viruses
Tissues derived from WAG-nu/nu rats were generously provided by
P. Poussier (University of Toronto, Canada). For in vivo experiments,
4- to 6-week-old female WAG or SD rats were infected intraperitone-
ally with 3 3 106 PFU of WT, DRCTL, or REV virus (RCMV-English
isolate). Rats were sacrificed on day 3 after infection, and blood,
spleens, and livers were harvested. NK-depleted animals received
one intravenous injection of rabbit polyclonal anti-asialo-GM-1
(150 mg) and 3.2.3 mAb (150 mg) 1 day prior to infection.
The DRCTL virus was described previously (Voigt et al., 2001). The
REV virus was generated via a pSK Bluescript transfer vector contain-
ing the 2.4 kb KpnR genomic fragment of RCMV-E that contains the
rctl gene. Transfer vector and DRCTL virion DNA were cotransfected
into REF cells, and recombinant virus was isolated as described pre-
viously (Voigt et al., 2001). Rescue of the rctl gene was confirmed by
Southern blot and sequencing (data not shown). Single and multistep
growth curves were performed to confirm the replication capacity of
the revertant, which was identical to the WT virus (data not shown).
Cell Culture and BWZ Reporter Assays
BWZ.36 (Sanderson and Shastri, 1994), 293T, and REF cells were cul-
tured as described (Carlyle et al., 2006; Voigt et al., 2001). Rat hema-
topoietic cells were processed with Lympholyte-Mammal (CedarLane
Laboratories, Mississauga, Canada), washed, and used directly, or
LAK cultured for cytotoxicity assays (see below). Eukaryotic and retro-
viral vectors, including the CD3z–NKR-P1B–RCTL fusion construct,
were generated and transfected as described elsewhere (Carlyle
et al., 2006; Mesci and Carlyle, 2007). BWZ assays were performed
as described (Mesci and Carlyle, 2007; Sanderson and Shastri,
1994) and quantitated via optical density readings at 595 nm versus
655 nm (OD595/655) with CPRG substrate. REF cells were infected
(WT, moi = 5) 18 hr prior to BWZ analysis.
RT-PCR and Real-Time RT-PCR
RNA extraction and cDNA preparation were performed as described
previously (Carlyle et al., 2006). Primer sequences are shown in Table
S2. All constructs were sequenced (Macrogen Inc., Seoul, South Ko-
rea) to confirm cDNA identities. For real-time RT-PCR, RNA was har-
vested from RCMV-infected REF cells (moi = 5) with the RNeasy
Mini Kit (Qiagen, Hilden, Germany), including on-column DNase treat-
ment. cDNA was made with RevertAid RT (Fermentas, St. Leon-Rot,
Germany), and samples were run on an ABI Prism 7900 HT Fast
Real-Time PCR System. RT-PCR experiments were controlled with
equal cDNA input.Flow Cytometry
The generation and characterization of R3A8 mAb has been described
in detail elsewhere (Mesci and Carlyle, 2007). In brief, mice were immu-
nized with BWZ.RCTL cells and immune splenocytes were used to
generate anti-RCTL hybridomas. Hybridomas were screened via
BWZ.RCTL stimulation on anti-(mouse IgG/M)-captured, immobilized
96-well arrays of hybridoma supernatants. One hybridoma clone
(R3A8) was selected for large-scale production and purification of
mAb, as described previously (Carlyle et al., 2004; Mesci and Carlyle,
2007). All other mAbs were purchased from BD Biosciences (Missis-
sauga, ON, Canada), e-Bioscience (San Diego, CA), or CedarLane or
were produced and purified in our own facilities. Streptavidin-PE
was purchased from Invitrogen (Burlington, ON, Canada). Flow cytom-
etry was performed as previously described (Carlyle et al., 2006). NK
depletion in vivo was confirmed by staining of splenocytes and blood
cells with 10/78 mAb, anti-NKR-P1A/B (CedarLane).
51Cr-Release Assays
Cytotoxicity assays were performed as previously described (Carlyle
et al., 2004). LAK cells were prepared by culturing splenocytes or
bone-marrow cells for 5 days in medium containing 2000 U/ml rhIL-2
plus 50 ng/mL mIL-15. REF target cells were infected with RCMV
WT or DRCTL virus overnight (moi = 5) or used directly, with or without
R3A8 blocking (25 mg/mL).
Quantification of Virus by Quantitative Real-Time PCR
DNA was isolated from tissues with the DNeasy Tissue Kit (Qiagen).
For quantitative real-time PCR (qPCR), parallel amplifications of the
RCMV-English glycoprotein B (gB) gene and host c-myc gene were
performed with standard conditions and specific primers and probes
(Table S2). Reactions were denatured (95C, 10 min), then monitored
for 45 cycles (95C, 15 s; 60C, 30 s) in parallel with control amplifica-
tions: negative controls, water; positive controls, plasmid dilutions
used to establish standard curves. Duplicated samples were aver-
aged, and Ct-values were further analyzed with ABI Prism SDS-Soft-
ware 2.2.2. Absolute quantification of gB and c-myc copy numbers
was obtained by standard curve analysis. Values were then normalized
by determination of the viral gB to host c-myc genomic copy ratio.
Quantification of Virus by Plaque-Forming Unit Analysis
Viral titers in spleens and livers were determined by a standard plaque-
forming unit (PFU) assays. Whole spleens and weighed liver samples
were homogenized, serially diluted, and plated on REF cells in 24-
well plates. Titers were read 6 days later after methylene blue staining.
Statistical Analysis
Statistical significance of differences between experimental groups for
RCMV infectious titers (PFU) and genomic copy numbers (qPCR) were
assessed by the Mann-Whitney exact rank sum test. Normalized PFU
titers and gB/c-myc ratios were considered significantly different for
p < 0.05.
Supplemental Data
Two figures and three tables are available at http://www.immunity.
com/cgi/content/full/26/5/617/DC1/.
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